Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Zhou, DM; Dejnirattisai, W; Supasa, P; Liu, C; Mentzer, AJ; Ginn, HM; Zhao, YG; Duyvesteyn, HME; Tuekprakhon, A; Nutalai, R; Wang, BB; Paesen, GC; Lopez-Camacho, C; Slon-Campos, J; Hallis, B; Coombes, N; Bewley, K; Charlton, S; Walter, TS; Skelly, D; Lumley, SF; Dold, C; Levin, R; Dong, T; Pollard, AJ; Knight, JC; Crook, D; Lambe, T; Clutterbuck, E; Bibi, S; Flaxman, A; Bittaye, M; Belij-Rammerstorfer, S; Gilbert, S; James, W; Carroll, MW; Klenerman, P; Barnes, E; Dunachie, SJ; Fry, EE; Mongkolsapaya, J; Ren, JS; Stuart, DI; Screaton, GR

Ren, JS; Stuart, DI (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Div Struct Biol, Oxford, England.; Mongkolsapaya, J; Screaton, GR (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England.; Mongkolsapaya, J; Stuart, DI; Screaton, GR (corresponding author), Univ Oxford, Chinese Acad Med Sci CAMS, Oxford Inst COI, Oxford, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Siriraj Hosp, Siriraj Ctr Res Excel

CELL, 2021; 184 (9): 2348

Abstract

The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began when the first sequence was published, and thi......

Full Text Link